Clinical Trials
20 trialsNCT07602907 2026-05-22
Metronomic Oral Paclitaxel Monotherapy and Combined Immunotherapy for Advanced HER2-Negative Breast Cancer: A Two-Stage Dose Exploration and Expansion Trial
Zhejiang Cancer Hospital
Phase 2 Not yet recruiting
NCT06618014 2026-05-15
NeoTOP
Sun Yat-sen University
Phase 2 Active not recruiting
NCT07378306 2026-04-21
FACT-TN
Sun Yat-sen University
Phase 2 Recruiting
NCT07540533 2026-04-20
2025-370
Henan Cancer Hospital
Phase 2 Recruiting
NCT07457359 2026-03-09
NEOTRIO-2
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase 2 Recruiting
NCT07410234 2026-02-13
Phase II Exploratory Study of Toripalimab Combined With SBRT in HER2-Negative Breast Cancer Patients With Insensitivity to Neoadjuvant Chemotherapy
Tianjin Medical University Cancer Institute and Hospital
Phase 2 Not yet recruiting
NCT07281976 2026-02-12
A Trial of LBL-024 Monotherapy or Combination Drug in Patients With Triple Negative Breast Cancer
Nanjing Leads Biolabs Co.,Ltd
Phase 1/2 Recruiting
NCT07383818 2026-02-03
Neoadjuvant Therapy Combined With Trastuzumab Rezetecan and Toripalimab for HR+/HER2-low Breast Cancer (NEOTORCH-BREAST 08)
First Affiliated Hospital of Zhejiang University
Phase 2 Recruiting
NCT06682195 2026-01-14
Neoadjuvant Chemotherapy Combined With Toripalimab for TNBC (NEOTORCH-BREAST02)
First Affiliated Hospital of Zhejiang University
Phase 2 Recruiting
NCT07111832 2025-12-18
A Clinical Trial of SHR-A1811 in the Treatment of Triple-negative Breast Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 3 Recruiting
NCT06735131 2025-12-03
The Optimal Radioimmunotherapy Combinations for Advanced TNBC
Sun Yat-sen University
Phase 2 Recruiting
NCT07256964 2025-12-02
Toripalimab Combined With Anthracycline-free or Anthracycline-containing Chemotherapy as Neoadjuvant Chemotherapy for Early Triple Negative Breast Cancer
Henan Cancer Hospital
Phase 2 Not yet recruiting
NCT07244874 2025-11-24
Sac-TMT Combined With Toripalimab for First-line Treatment of PD-L1 Positive a/mTNBC
Tianjin Medical University Cancer Institute and Hospital
Phase 2 Not yet recruiting
NCT06178159 2025-10-01
DV in Combination With Pertuzumab With or Without Toripalimab Neoadjuvant Therapy With HER2-positive Breast Cancer
RemeGen Co., Ltd.
Phase 2 Recruiting
NCT07169994 2025-09-12
A Study of YL202 in Combination With Other Anti-tumor Therapies in Patients With Advanced Solid Tumors
MediLink Therapeutics (Suzhou) Co., Ltd.
Phase 1/2 Recruiting
NCT07040644 2025-09-08
A Study of Sacituzumab Govitecan Plus Toripalimab Versus Toripalimab Plus Nab-Paclitaxel in PD-L1 Positive Advanced TNBC
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 2 Not yet recruiting
NCT06371274 2025-08-12
A Study on the Efficacy and Safety of Oral All-trans Retinoic Acid Combined With Toripalimab in TNBC.
First Affiliated Hospital of Zhejiang University
Phase NA Recruiting
NCT06611813 2025-08-12
Neoadjuvant Chemotherapy in Combination With Toripalimab for HR+/HER2- Breast Cancer (NEOTORCH-BREAST01)
First Affiliated Hospital of Zhejiang University
Phase 2 Recruiting
NCT07101614 2025-08-03
A Randomized Study of JS004 and Toripalimab Combined With Chemotherapy vs Toripalimab Combined With Chemotherapy vs Chemotherapy Alone as Neoadjuvant Therapy for Stage II-III Triple-negative Breast Cancer (TNBC).
Shengjing Hospital
Phase 2 Not yet recruiting
NCT06914440 2025-07-15
Neoadjuvant SBRT Followed by Nab-Paclitaxel Combined With Toripalimab in HR+/HER2- Breast Cancer
Xijing Hospital
Phase 2 Recruiting